You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ARWR Award Disclosure
Cohen Matthew Gregory · SEC Form 4 · Filed Jun 17, 2026
Award
Calculated transaction value
$0
Cohen Matthew Gregory Director
ARWR
Transaction date
Jun 15, 2026
Public filing date
Jun 17, 2026
Filing lag
Filed 2 days later
ARWR daily price context
Close on/before transaction
$77.15
Jun 15, 2026
First close after public filing
$81.82
Jun 18, 2026
30-day return after filing
-9.19%
Through Jul 17, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 11,882 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0002141314-26-000004
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Arrowhead Pharmaceuticals, Inc. ARWR Current | Award | Jun 15, 2026 | $0 |